chrisvoncsefalvay/vaers-outcomes huggingface dataset:
coughing white mucus 3 days after vaccine, fatigue day 1, shortness of breath on 2/24, 2/26 severe shortness of breath, admitted to er on 2/26
Bad headache; pain at location of injection; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number E13302), via an unspecified route of administration (arm right) on 15Jan2021 11:30 SINGLE DOSE for covid-19 immunisation, at 42 years old. Medical history reported as none. The patient is not pregnant. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient has no reported allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI FE), therapy date and indication unknown (received withing 2 weeks).  The patient experienced bad headache lasting over 24 hours, pain at location of injection for two days, and diarrhea on 15Jan2021 11:30. Treatment was not given. Outcome of the events was recovered on Jan2021. The reporter considered the events as non-serious.
Moderna vaccine was administered outside of Facility- reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------------ J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/18/2022 SYSTOLIC HEART FAILURE, ACUTE ON CHRONIC
Intusussception, Surgery required 02-01-08, associated with administration of ROTATEQ 01-29-08. 03/03/2008 MR received from PCP including vax record and hospital surgical report and F/U. DOS 2/1-2/2008 with DX: Intussusception. Child had first OV WCC on 1/29/08 with normal exam except eczema. Seen again 2/1/08 with c/o crying and decreased appetite.  Had bloody, mucusy stool in office. Transferred to hospital for eval and tx.  Air contrast enema (+) for Intussusception but unable to fully reduce.  Pt had an Exploratory Laparotomy, confirmation of intussusception, reduction and appendectomy. D/C next day. F/U OV with PCP doing well except for facial eczema. Surgical F/U 2/25/08 doing well.
Patient received vaccine and initially had soreness at the injection site for about 2 weeks. On 11/29 she noticed redness and warmth in addition to pain in the area. This initally improved without any treatment. Symptoms began to worsen again (redness, pain, warmth in the deltoid area of the arm) and she was seen at an urgent care facility on 12/9 and was given Keflex 250mg TID. Symptoms continued to worsen. She presented to the Emergency Department on 12/13/08 and was given a 1 gram dose of Vancomycin IV and was ultimately discharged home on Keflex 500mg QID and Bactrim DS - 1 tab BID. Patient reports initial improvement after the antibiotic change but then symptoms again worsened and she returned to the ED on 12/16/08 and was admitted to the hospital for IV antibiotics with worsening erythema and pain. She is currently on vancomycin IV and Clindamycin IV was added today because symptoms are not significantly improving. There is no abcess associated with the cellululitis. Patient is still in the hospital- anticipated discharge date unknown. 2/2/09-records received for DOS 12/16-12/19/08 DC DX:Myositis/fascitis.Presented to ER with 6 week history of LUE cellulitis at which time received 3rd gardasil  injection in left arm. After injection noticed army sore 1 week later with red ring around injeciton site and treated with oral antibiotics. LUE pain worsing and redness spreading, decreased ROM, fever feeeling lethergic/fatigued. Presented with chills decreased oral intake.
The client was given two doses of pediatric recombivax-1st dose given 08/31/2023, 2nd dose given 10/17/2023. This nurse made the first error by taking a pediatric dose from the refrigerator due to the adult dose being labeled for a local employer only. The second dose was given by another nurse in the facility after the Immunization Coordinator had obtained it from the refrigerator for the nurse. Staff have been unable to contact the patient to report the adverse event due to the patient's phone number that the facility has on file has been disconnected.
70 x 80 mm erythema around 1 cm eschar(?) right arm. On day 10 - diffuse morbilliform rash over back, chest, abdomen, especially groin toxilla. None on arms, legs, face.
A couple months after my 2nd Covid shot, I visited the ER with left chest pain. EKG showed right (left?) bundle block incidentally and compared it to an EKG that was take less than a year earlier. It was not there.  The pain turned out to be from a frozen shoulder, for which I had local anesthesia  and physical  therapy.   In June, I saw my GP who ordered labs that showed kidney disease. It was discovered that the ER did not read the results of all my tests, so it was confirmed.  Dr. is my kidney specialist who diagnosed me with severe kidney disease based on labs. Side effects include weight loss, and altered taste. I have lost over 100#s without even trying. Biopsy of my left kidney proved negative.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported. No treatment information was provided.   This case was linked to  (Patient Link).
used a vial that was first punctured yesterday ( 26Aug2021 ) at 8:28 am; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (used a vial that was first punctured yesterday ( 26Aug2021 ) at 8:28 am) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (used a vial that was first punctured yesterday ( 26Aug2021 ) at 8:28 am). At the time of the report, EXPIRED PRODUCT ADMINISTERED (used a vial that was first punctured yesterday ( 26Aug2021 ) at 8:28 am) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   NO concomitant medication was reported No treatment drug was reported   Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Follow-up received on 31-AUG-2021: contains no new information
Gota  a transient scheme stroke on April 8th,2021 when a blood clots went to my right side brain. I was shown  by an MRI , when I was admitted to the ER. I Was hospitalized for 3 days and all the hospital test   and future cardio and neurological tests not shoed any reasonable causes for developing the blood clothes and a stroke , as the Lipid test as well showed that my cholesterol, blood pressure ,weight and sugar level were in normal ranges. Given that Y have a family history of cardiovascular conditions  I maintain councioly my good health condition,the only different in my health was getting my second dose of the Pfizer vaccine on March 19,2020 three weeks before I developed the schema stroke.
Right leg swollen, red and no weight bearing; mildly tender to touch. Motrin and Benadryl Q 6 hours. DTaP given in right thigh.
the patient did not experience any side effects.; patient who is 5 weeks and 1 day old was administered a few drops of ROTATEQ on 10/27/2022.; patient who is 5 weeks and 1 day old was administered a few drops of ROTATEQ on 10/27/2022.; This spontaneous report was received from a medical assistant regarding a 5-week-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 27-OCT-2022, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) taken orally (strength, dosage regimen, lot #, and expiry date were not provided) for prophylaxis (Product administered to patient of inappropriate age). It was reported that the patient received a few drops of the vaccine (Incorrect dose administered). She did not experience any side effects. The patient did not received treatment and did not sought medical attention.
A red, itchy rash appeared mainly in the center of my neck 3 days after vaccine; continued to be itchy/dry after almost one week, but appearance got better and no longer red; treated w/hydrocortisone cream (OTC) and resolved itself after ~10 days. Other symptoms included slight burning of skin along my chin, lower cheeks, ear lobes, and scalp, but no visible rash in those places. (These also resolved after ~10 days.)
itchy welts on legs and arms, lasting for 4-5 days after, after 2 nd dose, one left leg and arm again lasting for 4-5 days, then then staring again on the 17th of March.
Swelling of lymph nodes and skin around shoulder area. Painful underarm and visible nodes around collar bone. Area is hot to the touch. Site looks normal.
Fever, Body ache, Chills, Injection site pain irradiating to the neck, Headache.
Symptoms were described as brain thoughts were not connecting. "brain fog".  I could think but the thoughts could not be connected with other thoughts.  I was not slurring or had no weakness or numbness in limbs.  I just could not process thoughts.  It is difficult to describe. I could think thoughts, but my brain had a sense of confusion.  This occurred for 3-4 hours and resolved about 6 hours afterwards and the next day all was fine.  I called my primary care physician and I decided to watch and wait.
vial was initially stored in the refrigerator on 13-Sep-2022, date of administration of vaccine 18-Oct-2022; No adverse event; Patient was administered expired bivalent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered expired bivalent dose), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 13-Sep-2022, date of administration of vaccine 18-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered expired bivalent dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 13-Sep-2022, date of administration of vaccine 18-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered expired bivalent dose), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 13-Sep-2022, date of administration of vaccine 18-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered expired bivalent dose) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 13-Sep-2022, date of administration of vaccine 18-Oct-2022).    No concomitant medication was provided.  Patient received Moderna for the primary doses.  The patient had Moderna bivalent booster that expired on 13-Oct-2022.   Dose administered after 30-day use by date  Vial was initially stored in the refrigerator 13-Sep-2022 and the vial size was 2.5 ml.  Vial did not undergo any temperature excursions.  Treatment medication was not provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-661306 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-661306:same reporter
Night if vaccine administered tightness in chest at bedtime. Next day more severe tightness in chest, restricted vocal chords and dizzy spells. Dizzy spells lasted 2 days, tightness in chest and restricted vocal chords lasted 7 days. Lost voice and clogged ears as result of bodily trauma.
Patient returned to Pharmacy 10/11 to report that she's had arm pain with restricted motion since being immunized. Has seen her physician.
This spontaneous report as received from a physician via a field employee refers to a young girl of unknown age. On an unspecified date at an unspecified time, the patient was vaccinated with a dose of GARDASIL injection, 0.5 ml, once, intramuscular (lot # and expire date were not reported). Concomitant therapy was not reported. The patient waited 30 minutes in office post vaccination then went to a local restaurant nearby (unspecified) where she fainted. An ambulance was called by restaurant personnel, the patient was determined to be "fine" and did not go to emergency department. A report of incident was made to an unspecified source. The patient present status was reported as "doing fine". The relationship between adverse event and GARDASIL was not reported. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
about 4 weeks after my shot I started a post menopausal cycle after 6 years without a period
Patient developed signifcant bruising in response to minimal trauma, had a spontaneous nose bleed, and had bleeding gums starting around January 23rd.  Blood work obtained on 1/31 showed a low platelet count at 52,000.  Repeat count on 2/1 was 42,000.
itching; large welts; This case was reported by a nurse via sales rep and described the occurrence of pruritus in a 69-year-old male patient who received Flu Seasonal TIV Dresden (Fluarix) for prophylaxis.   The patient's past medical history included adverse reaction (took a medication that may had caused the reaction which he had a reaction to in the past).   On an unknown date, the patient received Fluarix. On an unknown date, less than a day after receiving Fluarix, the patient experienced pruritus and welts. On an unknown date, the outcome of the pruritus and welts were unknown.   It was unknown if the reporter considered the pruritus to be related to Fluarix. The reporter considered the welts to be unrelated to Fluarix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Fluarix and woke up in the night with itching and large welts.  The patient went to urgent care and took a medication that may had caused the reaction which had a reaction to in the past, but patient felt the reaction was due to the Fluarix. The reporter tested him to the vaccine, and it was negative and thinks that he had underlying urticaria not related to the vaccine.
6cm area of erythema, noted left lateral thigh. 2cm area of raised, red lesions left lateral thigh.
Redness, heat, and swelling around upper arm and spread to bicep reported to start the next day---Patient iced it and took acetaminophen and she reported improvement. There is still some swelling today (10 days after injection), but it is improving
Patient developed malaise,palpitations, chest pressure two days after vaccine.  She was ultimately hospitalized twice for 5 days each time, with a myocardial infarction and then to have 3 stents placed. Since this event she now requires insulin whereas prior she was pre-diabetic.
Petichia and N/V for 2 wks post rabies prophylactic series.
Initial case received on 30 May 2014 from a consumer. A female patient had received on 10 August 2010 an intramuscular left deltoid injection of FLUZONE, lot number U3575FA and an unspecified amount of time later after vaccination, experienced erythema multiforme over her entire body. Treatments and diagnostic testing were not reported. Outcome was unknown. Documents held by sender: none.
The patient received the third/booster dose of BNT162b2.; Chills; Aches; Fever; Sore arm; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. An adult non-pregnant female patient of unspecified age received third/booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 04Nov2021 as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 24Feb2021 and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 17Mar2021 as a single dose for COVID-19 immunisation. On 04Nov2021, the patient experienced chills, aches, fever, sore arm and fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, aches, fever, sore arm and fatigue were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
migraines; anxious; headache; This is a spontaneous report from a contactable consumer, the patient.  A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL1283), intramuscularly, on 23Jan2021 at 11:30 (at the age of 76-years-old) as a single dose in the left arm for COVID 19 vaccination. Medical history included stress related to work and a preservatives allergy which give her headaches. Historical vaccinations included pneumonia vaccine (UNKNOWN MANUFACTURER but reported as "Pneumonia 13") on an unspecified date "four years ago" after which she developed a headache which she attributes to an allergy to unknown preservatives. She never received the second "Pneumonia 13" because of the reaction with the first one. She also reported that she has had this same reaction of headache attributed to allergy to unknown preservatives when eating fast foods and foods with sauces. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The vaccine was administered at a  Convention Center.  On 23Jan2021 at 11:45, fifteen minutes after she received the vaccination, the patient developed a headache which she has had ever since she got in on Saturday. She also stated that it feels like "a migraine on steroids."  She did tell the person at the clinic where she received it. She stated that she is "hypoallergenic" and she had to sit for thirty minutes after receiving it. She was already anxious and about fifteen minutes in, she developed the headache and nothing has helped so far. She added that she has not had a headache in a long time and that is why she feels it is the shot. She reported that what she took for treatment did not work. These treatments included: Acetaminophen Extra Strength 500mg NDC 21130-111-90. Lot 9ME2806A, expiration 20Jul2021. Count size is 500 caplets, Motrin Ibuprofen tablets 200mg. Lot 6ME1058A, Expiration Sep2018. Count size 100 caplets which when taken was an expired product, SalonPas Roll On Lot 192498, Expiration Jan2022. Count size is 1 container with 3 fluid ounces or 88ml and Neck Wrap and Wrist Heat Wraps which is reported as "a generic equivalent of Thermacare" with Lot number 91211OC16, Expiration 10Dec2022. She did not take the heavy duty Motrin because it was out of date. She commented that all of these things had helped in the past. The clinical outcomes of the event headache, migraine and anxiety were reported as unknown.
Within 30 minutes after TDAP administration experienced disorientation, weakness generalized, shortness of breath, tingling of arms. No localized reaction.
13 yr old male given pediatric (5-11yr old) dose 0.2mL during mass vaccine clinic.  No adverse outcomes noted.
Having prolonged pain in neck- Left- with vertigo whenever I get up falling to the left.  Very unstable.    Chills every day beginning around noon, lasting until around 5pm.  whole body shakes.      Wondering if this is going to be lasting for a short time?
Patient developed warmth, clamminess, nausea and lightheadedness shortly after her shot. She admitted to near syncope, but there was no LOC. No tunnel vision. Symptoms resolved on their own. VVS throughout.   No orthostasis.
Painful & Swollen axillary lymph nodes on armpit side of injection site; Painful & Swollen axillary lymph nodes on armpit side of injection site; This is a spontaneous report from a non-contactable nurse reported for herself.   This 22-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in left arm on 17Feb2021 13:00 (Lot Number: EL9267) as single dose (at 22 years old) for COVID-19 immunisation. Medical history included COVID-19 prior vaccination on an unknown date, known allergies: Penicillin. There were no concomitant medications. The patient experienced painful & swollen axillary lymph nodes on armpit side of injection site on 18Feb2021 with outcome of unknown. No treatment required. The patient had not been tested for COVID-19 post vaccination.  No follow-up attempts are possible. No further information is expected.
Within 15 minutes of receiving vaccine, patient began to experience severe chest pain/tightness, elevated blood pressure and pulse and broke out in a cold sweat.  EMS was called.   Follow up 30 minutes after leaving facility - EMS was still monitoring the patient Follow up the next day (6/29/21) - patient was unable to be reached to get an update on status